New research suggests the HPV vaccine is preventing cancer in men, as well as in women, but fewer boys than girls are getting the shots in the United States.
The Leonardo Dual Diode Laser from Biolitec is an alternative for the treatment of genitourinary syndrome of menopause, according to new study results.
99.8% of cervical cancer cases are caused by persistent high-risk HPV infections, while the virus is also linked to throat and oral cancer, as well as fertility problems.
The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.
SAN JOSE, Calif., May 13, 2024 /PRNewswire/ — Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation (EU) 20147/745, for its state-of-the-art Aveta Hysteroscopy System. With this significant milestone achieved, Meditrina is thrilled to enter international markets, marking a pivotal moment in the company’s commitment to advancing women’s health globally.
Freyja Healthcare Brings First-of-Its-Kind 2mm Abdominal-Access Device to Laparoscopic Surgery to Further Innovation in Fast-Growing Women’s Health Market
Lumicell developed the technology to help physicians detect residual cancer in the breast cavity after surgery.
Lumicell today announced it received FDA approval for its LumiSystem direct visualization system for breast cancer removal.
Highmark BCBS and BCBS of North Dakota cover the Leva Pelvic Health System for women seeking effective treatment for urinary incontinence
The Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) of the Lumerah™ technology for the early detection of fetal distress during labor and delivery.